Clinical Trial: Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury

U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07795736) titled 'Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury' on Aug. 26.

Brief Summary: The goal of this observational study is to characterize the impact of growth hormone deficiency (GHD) on quality of life, symptom burden, and sleep in adults with traumatic brain injury (TBI), and to evaluate whether these outcomes improve with growth hormone replacement therapy.

The main questions it aims to answer are:

* Does quality of life, as measured by the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA), differ between adults with TBI and GHD compared to those with TBI and no GHD?

* Do fatigue, cogn...